Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
Charleen D Adams Beckman Research Institute, Duarte, CA, USACorrespondence: Charleen D AdamsBeckman Research Institute, City of Hope,1500 E. Duarte Road, Duarte, CA, USATel +1 626-841-3931Fax +1 626-841-9204Email chaadams@coh.orgBackground: Alzheimer’s disease is a devastating neurodegener...
Guardado en:
Autor principal: | Adams CD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb265a3e11524b8db97f3a0f8bdf60cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010) -
Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008) -
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009) -
Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018) -
Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)